Factors Affecting the Formation of a Skin Reservoir for Topically Applied Solutes

Skin Pharmacology and Physiology

Volumn 17, Issue 1, 2004, Pages 3-16

  Roberts, M S ^a   Cross, S E ^a   Anissimov, Y G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Reservoir function, skin; Stratum corneum; Topical solute

Indexed keywords

ACETYLSALICYLIC ACID; BENZO[A]PYRENE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CHLORPHENOTANE; CORTICOSTEROID; DEXTRAN; DICLOFENAC; DIMETHYL SULFOXIDE; ESTRADIOL; FLUOCINOLONE; FLUOCINOLONE ACETONIDE; FUSIDATE SODIUM; FUSIDIC ACID; HALCINONIDE; HYDROCORTISONE; SALICYLIC ACID; STEROID; TRIAMCINOLONE ACETONIDE; TRICLOCARBAN;

BLOOD PRESSURE; COMPARTMENT MODEL; CONCENTRATION RESPONSE; CREAM; DESQUAMATION; DRUG DIFFUSION; DRUG SOLUBILITY; EPIDERMIS; HUMAN; LIPOPHILICITY; NONHUMAN; PRIORITY JOURNAL; RESERVOIR; REVIEW; SKIN; STEROID BLOOD LEVEL; STRATUM CORNEUM; TISSUE PERFUSION; VASOCONSTRICTION;

ADMINISTRATION, CUTANEOUS; ADRENAL CORTEX HORMONES; CHEMISTRY, PHARMACEUTICAL; EPIDERMIS; HUMANS; MODELS, BIOLOGICAL; PHARMACOKINETICS; SKIN; SKIN PHYSIOLOGY; SOLUTIONS; TIME FACTORS;

EID: 1342301603     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074057     Document Type: Review

References (44)

1. Vickers CF: Stratum corneum reservoir for drugs. Adv Biol Skin 1972;12:177-189.
2. Guillot M: Physiochemical conditions of cutaneous absorption J Physiol 1954;46:31-49.
3. Schaefer H, Stuttgen G, Zesch A, Schalla W, Gazith J: Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin. Curr Probl Dermatol 1978;7:80-94.
4. Malkinson FD, Ferguson EH: Percutaneous absorption of hydrocortisone-4-C14 in two human subjects. J Invest Dermatol 1955;25:281-283.
5. Sulzberger MB, Hermann F: On some characteristics and biological functions of the skin surface. Dermatologica (Basel) 1961;123:1-23.
6. Vickers CFH: Existence of reservoir in the stratum corneum - Experimental proof. Arch Dermatol 1963;88:20-33.
7. Roberts MS, Anissimov Y, Gonsalvez R: Mathematical models in percutaneous absorption; in Bronaugh RL, Maibach HI (eds): Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methodology, ed 3. New York, Dekker, 1999, pp 3-55.
8. Carr RD, Wieland RG: Corticosteroid reservoir in the stratum corneum. Arch Dermatol 1966;94:81-84.
9. Zesch A, Schaefer H, Hoffmann W: Barrier and reservoir function of individual areas of the horny layers of human skin for locally administered drugs. Arch Dermatol Forsch 1973;246:103-107.
10. Roberts MS, Walker M: Water - The most natural penetration enhancer; in Walters KA, Hadgraft J (eds): Skin Penetration Enhancement. New York, Dekker, 1993, pp 1-30.
11. Barry BW, Woodford R: Comparative bioavailability and activity of proprietary topical corticosteroid preparations: Vasoconstrictor assays on thirty-one ointments. Br J Dermatol 1975;93:563-571.
12. Anderson BD, Higuchi WI, Raykar PV: Heterogeneity effects on permeability - Partition coefficients in human stratum corneum. Pharm Res 1988;5:566-573.
13. 3H- norethindrone acetate transport across human epidermis as a function of time. Acta Derm Venereol Suppl (Stockh) 2000;208:36-43.
14. Siddiqui O, Roberts MS, Polack AE: Percutaneous absorption of steroids: Relative contributions of epidermal penetration and dermal clearance. J Pharmacokinet Biopharmacol 1989;17:405-424.
15. Anissimov Y, Roberts MS: Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration. J Pharm Sci 1999;88:1201-1209.
16. Dupuis D, Rougier A, Roguet R, Lotte C, Kalopissis G: In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat. J Invest Dermatol 1984;82:353-356.
17. Rougier A, Dupuis D, Lotte C, Roguet R, Schaefer H: In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J Invest Dermatol 1983;81:275-278.
18. Rougier A, Dupuis D, Lotte C, Roguet R, Wester RC, Maibach HI: Regional variation in percutaneous absorption in man: Measurement by the stripping method. Arch Dermatol Res 1986;278:465-469.
19. Dupuis D, Rougier A, Roguet R, Lotte C: The measurement of the stratum corneum reservoir: A simple method to predict the influence of vehicles on in vivo percutaneous absorption. Br J Dermatol 1986;115:233-238.
20. Stokes RP, Diffey BL: The water resistance of sunscreen and day-care products. Br J Dermatol 1999;140:259-263.
21. 14C]benzo[a] pyrene from soil. Fundam Appl Toxicol 1990;15:510-516.
22. Billhimer WL, Berge CA, Englehart JS, Rains GY, Keswick BH: A modified cup scrub method for assessing the antibacterial substantivity of personal cleansing products. J Cosmet Sci 2001;52:369-375.
23. Dessler W. Percutaneous absorption of hair dyes; in Roberts MS, Walters KA (eds): Dermal Absorption and Toxicity Assessment. New York, Dekker, 1998, pp 489-536.
24. Bucks DAW: Predictive approaches. II. Massbalance procedure; in Shah VP, Maibach HI (eds): Topical Drug Bioavailability, Bioequivalence and Penetration. New York, Plenum Press, 1993, pp 183-195.
25. Clarys P, Gabard B, Barel AO: A qualitative estimate of the influence of halcinonide concentration and urea on the reservoir formation in the stratum corneum. Skin Pharmacol Appl Skin Physiol 1999;12:85-89.
26. McCarley KD, Bunge AL: Pharmacokinetic models of dermal absorption. J Pharm Sci 2001;90:1699-1719.
27. Turpeinen M: Absorption of hydrocortisone from the skin reservoir in atopic dermatitis. Br J Dermatol 1991;124:358-360.
28. Schaefer H, Redelmeier M: Skin Barrier. Basel, Karger, 1996, pp 40-42.
29. Roberts MS, Walters KA: The relationship between structure and barrier function of skin; in Roberts MS, Walters KA (eds): Dermal Absorption and Toxicity Assessment. New York, Dekker, 1998, vol 91, pp 1-42.
30. Reddy MB, Guy RH, Bunge AL: Does epidermal turnover reduce percutaneous penetration? Pharm Res 2000;17:1414-1419.
31. Benowitz NL, Lake T, Keller KH, Lee BL: Prolonged absorption with development of tolerance to toxic effects after cutaneous exposure to nicotine. Clin Pharmacol Ther 1987;42:119-120.
32. Chambin-Remoussenard O, Treffel P, Bechtel Y, Agache P: Surface recovery and stripping methods to quantify percutaneous absorption of caffeine in humans. J Pharm Sci 1982;11:1099-1101.
33. Yagi S, Nakayama K, Kurosaki Y, Higaki K, Kimura T: Factors determining drug residence in skin during transdermal absorption: Studies on beta-blocking agents. Biol Pharm Bull 1998;21:1195-1201.
34. Potard G, Laugel C, Schaefer H, Marty J-P: The stripping technique: In vitro absorption and penetration of five UV filters on excised fresh human skin. Skin Pharmacol Appl Skin Physiol 2000;13:336-344.
35. Menczel E, Maibach HI: Chemical binding to human dermis in vitro: Testosterone and benzyl alcohol. Acta Derm Venereol 1972;52:38-42.
36. Menczel E, Bucks D, Maibach H, Wester R: Malathion binding to sections of human skin: Skin capacity and isotherm determinations. Arch Dermatol Res 1983;275:403-406.
37. Bronaugh RL, Congdon ER: Percutaneous absorption of hair dyes: Correlation with partition coefficients. J Invest Dermatol 1984;83:124-127.
38. Lee AR, Tojo K: An experimental approach to study the binding properties of vitamin E (α-tocopherol) during hairless mouse skin permeation. Chem Pharm Bull (Tokyo) 2001;49:659-663.
39. Baker JR, Christian RA, Simpson P, White AM: The binding of topically applied glucocorticoids to rat skin. Br J Dermatol 1977;96:171-178.
40. Liu P, Higuchi WI, Ghanem AH, Good WR: Transport of beta-estradiol in freshly excised human skin in vitro: Diffusion and metabolism in each skin layer. Pharm Res 1994;11:1777-1784.
41. Borsadia S, Ghanem AH, Seta Y, Higuchi WI, Flynn GL, Behl CR, Shah VP: Factors to be considered in the evaluation of bioavailability and bioequivalence of topical formulations. Skin Pharmacol 1992;5:129-145.
42. Walter K, Kurz H: Binding of drugs to human skin: Influencing factors and the role of tissue lipids. J Pharm Pharmacol 1988;40:689-693.
43. Singh P, Roberts MS: Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J Pharm Sci 1994;83:783-791.
44. Roberts MS, Cross SE: A physiological pharmacokinetic model for solute disposition in tissues below a topical application site. Pharm Res 1999;16:1394-1400.